Skip to main content
Premium Trial:

Request an Annual Quote

Bruker's Preliminary Q2 Revenues Miss Estimates, Stock Tumbles

NEW YORK (GenomeWeb News) – Bruker today announced preliminary second-quarter revenues of $420 million, falling short of analyst estimates of $434.5 million.

The company posted revenues of $401.2 million a year ago. Bruker is scheduled to report its second-quarter earnings on July 31.

Bruker added that EPS for the second quarter is expected to be in the range of $.05 and $.07, while adjusted EPS is expected to fall between $.11 and $.13, which would also miss a consensus Wall Street estimate of $.21.

The firm said that financial results for the quarter were adversely affected by a weaker Euro, softening customer demand, especially in Europe, and increases in spending.

News of the announcement drove down shares of Bruker 13 percent to $11.64 in Tuesday morning trading on the Nasdaq. Its shares had fallen as low as $9.91 earlier in the day.

Following the announcement, Jefferies analyst Jon Wood lowered EPS estimates for 2012 to $.75 from $.95 and 2013 EPS to $.85 from $1.10. Wood lowered the price target for Bruker's stock to $15.50 from $19.

William Blair analyst Amanda Murphy said in a research note, "While we believe that the stock had accounted for the impact of weaker sales (given the company's prior commentary), the adjusted EPS guidance implies meaningful sequential and year-over-year margin deterioration.

"The key to the story, in our view, was the margin expansion opportunity (management had guided to 120 to 140 basis points for the year) via continued integration of [its Chemical and Applied Markets division] as well as sourcing noncore products to lower-cost countries and a continued mix shift to new products with a lower cost base. Thus, we view this to be the most disappointing component of the preannouncement," she said.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.